510(k) Report

510(k) · Cleared

Cleared

2010 Plus Holter for Windows

K003940510(k) SpecialCleared Feb 8, 200149-day reviewClass II21 CFR 870.2800

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Agilent Technologies · MLO Electrocardiograph, Ambulatory, With Analysis Algorithm

Cleared on Feb 8, 2001 as substantially equivalent to K990170 (Zymed Medical Instrumentation, 1999) and 2 other predicates after a 49-day review. Its family tree reaches back 3 generations to 1994. 1 later device descends from it.

Decided
Feb 8, 2001
Review
49 days
Class
Class II
Product code
MLO
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K930806 (1994). 5 ancestors in all, the oldest K895208 (1989). 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1998: 1 other ancestor1989: 1 other ancestor2015: 1 descendant clearedK930806 · Zymed Holter Scanner Model 2010 · Agilent Technologies · 1994K955015 · Zymed Holter Scanner Model 2010 · Zymed Medical Instrumentation · 1996K990170 · Holter 2000 · Zymed Medical Instrumentation · 19991990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors 1 generation forward: 1 descendant K990170 · Holter 2000 · Zymed Medical Instrumentation · 1999K955015 · Zymed Holter Scanner Model 2010 · Zymed Medical Instrumentation · 1996K930806 · Zymed Holter Scanner Model 2010 · Agilent Technologies · 19940
  1. Root · 3 generations backK930806 Zymed Holter Scanner Model 2010Agilent Technologies · 1994
  2. 2 generations backK955015 Zymed Holter Scanner Model 2010Zymed Medical Instrumentation · 1996
  3. 1 generation backK990170 Holter 2000Zymed Medical Instrumentation · 1999
  4. This deviceK003940 2010 Plus Holter for WindowsAgilent Technologies · 2001
  5. Descendant · cites it directly · 0 of its ownK142349 TM eCloud ECG Analysis SystemTelemed Solutions, Inc. · 2015

Most influential descendants

Showing 1 of 1 · See all
  • K142349TM eCloud ECG Analysis SystemTelemed Solutions, Inc. · 2015 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K930806Zymed Holter Scanner Model 2010Agilent Technologies1994—
−2K955015Zymed Holter Scanner Model 2010Zymed Medical Instrumentation1996—
−1K990170Holter 2000Zymed Medical Instrumentation1999—
0 (this device)K0039402010 Plus Holter for WindowsAgilent Technologies2001—
+1K142349TM eCloud ECG Analysis SystemTelemed Solutions, Inc.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910
199810

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
FIG. 1 — Lineage of K003940, 1994–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MLO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MLO device

  1. #1 K261580 ZBPro Diagnostic (Version 2.0)score 13.8 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K990170Holter 2000
Summary page 1
…ardiograph, ambulatory, with analysis algorithm (per 21 CFR 870.2800) Legally marketed device to which S.E. is claimed. Zymed Holter Scanner Model Holter 2000 —- 510(k) K990170 Zymed Holter Scanner Model 1610 — 510(k) K895208 Biosensor’s Holter Monitor System — 510(k) K974192 Description: The 2010 Plus H…
Zymed Medical Instrumentation1999—
*K895208Zymed Model 1610
Summary page 1
…per 21 CFR 870.2800) Legally marketed device to which S.E. is claimed. Zymed Holter Scanner Model Holter 2000 —- 510(k) K990170 Zymed Holter Scanner Model 1610 — 510(k) K895208 Biosensor’s Holter Monitor System — 510(k) K974192 Description: The 2010 Plus Holter for Windows is a device that analyzes recor…
Agilent Technologies1989—
*K974192Biosensor Holter Monitor System
Summary page 1
…ich S.E. is claimed. Zymed Holter Scanner Model Holter 2000 —- 510(k) K990170 Zymed Holter Scanner Model 1610 — 510(k) K895208 Biosensor’s Holter Monitor System — 510(k) K974192 Description: The 2010 Plus Holter for Windows is a device that analyzes recorded cardiac ECG and creates reports from the record…
Biosensor Corp.1998—

Also cleared against K990170: 3 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K142349TM eCloud ECG Analysis SystemTelemed Solutions, Inc.20150

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 2 companies; a new generation was cleared every 1.9 years on median.
  • None of the 5 ancestors has a recall.
  • Of its descendants, K142349 (Telemed Solutions, Inc., 2015) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K990170.

How does its category compare?

All MLO devices

MLO Electrocardiograph, Ambulatory, With Analysis Algorithm: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MLO

1in 2025

2007: 12010: 12011: 32012: 12013: 22014: 12018: 12020: 22024: 12025: 12026 (partial year): 1
2007high 3 (2011) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MLO

238in 2011

2011: 238 days median
2007high 238 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MLO

2in 2024

2024: 2
2007high 2 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MLO

4in 2025

2009: 52010: 12011: 12014: 12017: 12018: 12019: 12021: 12022: 12023: 12024: 22025: 4
2007high 5 (2009) · low 0 (2007)2025

MAUDE reports naming product code MLO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20090—05
20101—01
2011323801
20121—00
20132—00
20141—01
20150—00
20160—00
20170—01
20181—01
20190—01
20202—00
20210—01
20220—01
20230—01
20241—22
20251—04
20261—0—

What is it indicated for?

Assessment of symptoms that may be related to rhythm disturbances of the heart in patients from pediatric to adult age. Patients with palpitations. Assessment of risk in Patients With or Without Symptoms of Arrhythmia. Patients with symptomatic or asymptomatic idiopathic hypertrophic cardiomyopathy and postmyocardial infarction patient with left ventricular dysfunction using arrhythmia e.g.: ventricular ectopy, as method of risk assessment. Assessment of…

Read the full statement (125 words)

Assessment of symptoms that may be related to rhythm disturbances of the heart in patients from pediatric to adult age. Patients with palpitations.

Assessment of risk in Patients With or Without Symptoms of Arrhythmia. Patients with symptomatic or asymptomatic idiopathic hypertrophic cardiomyopathy and postmyocardial infarction patient with left ventricular dysfunction using arrhythmia e.g.: ventricular ectopy, as method of risk assessment.

Assessment of efficacy of Antiarrhythmia Therapy. Patients with baseline high frequency, reproducible, sustained, symptomatic premature ventricular complexes supraventncular arrhythmia or ventricular tachycardia.

Assessment of Pacemaker Function. Evaluation of patients with paroxysmal symptoms, detection of myopotential inhibition, detection of pacemaker mediated tachycardia, evaluation of antitachycardia pacing device function, evaluation of rate-responsive physiological pacing function.

Detection of Myocardial Ischemia. Patients with chest pain suggestive of Prinzmetal’s angina.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K003940: 2010 Plus Holter for Windows.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K003940

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026